The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
Elaine R. Silveira(Universidade de São Paulo), Claudimara Ferini Pacicco Lotfi(Universidade de São Paulo)
Cited by 14